Correction to: J Exp Clin Cancer Res (2018) 37: 282
https://doi.org/10.1186/s13046-018-0960-7
In the original publication of this article [1], Fig. 3 is wrong, but does not affect discussions and conclusions drawn in the article.
The corrected Fig. 3 is shown below:
.
Reference
Yao Y, et al. Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. J Exp Clin Cancer Res. 2018;37:282. https://doi.org/10.1186/s13046-018-0960-7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Yao, Y., Guo, Q., Cao, Y. et al. Correction to: Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. J Exp Clin Cancer Res 38, 451 (2019). https://doi.org/10.1186/s13046-019-1441-3
Published:
DOI: https://doi.org/10.1186/s13046-019-1441-3